Friday 6 November 2026 Export PTCT’s income statement to Excel — free account

PTC Therapeutics, Inc.

PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.

Revenue: +69.6%
EPS: −409.7%
Free cash flow: +90.3%
Total debt: +19.3%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

65.55 0.12 −0.18%

Follow PTCT

Alert me

Market cap: $5.5B
P/E: 0.0×
Fwd P/E: 42.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.86
Beneish M: −1.48
Dividend safety: n/a

Overview

PTC Therapeutics, Inc. (PTCT) P/B ratio

Alert me on P/B ratio

PTC Therapeutics, Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 2,186× (February 2022) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PTCT/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="PTC Therapeutics, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PTCT/metrics/pb-ratio">PTC Therapeutics, Inc. (PTCT) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	1,952×	23,245.12%
FY2020	8.4×	75.75%
FY2019	4.8×	4.37%
FY2018	4.6×	4.22%
FY2017	4.4×	36.79%
FY2016	3.2×	(33.68%)

Period	P/B ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 2,186×

Ten-year median 3.6×

Current reading's percentile 39

Company	P/B ratio
MIRM Mirum Pharmaceuticals, Inc. compare	n/m
PTCT PTC Therapeutics, Inc.	n/m
CGON CG Oncology, Inc. compare	5.6×
MANE Veradermics Incorporated compare	6.4×
BLTE Belite Bio, Inc. Sponsored ADR compare	7.5×
IMVT Immunovant, Inc. compare	8.0×
COGT Cogent Biosciences, Inc. compare	10.9×
SRRK Scholar Rock Holding Corporation compare	23.5×
KOD Kodiak Sciences Inc. compare	94.0×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

PTC Therapeutics, Inc. (PTCT) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on PTCT

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on PTCT

Stockrow Weekly